SEOUL, May 2 (Korea Bizwire) – Cancer deaths have increased by 72 percent in the past decade, with lung cancer being most commonly diagnosed, followed by liver, stomach, pancreas, colon and breast cancer. According to the Korea Insurance Development Institute on Wednesday, the number of life insurance subscribers who died of cancer increased from 18,144 [...]
Paris, France; Cambridge, Massachusetts (USA); Apr. 2 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the ‘‘Company’’) a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced preclinical data from studies currently being conducted under its collaborations with The University of Texas MD Anderson Cancer Center and the Weill Cornell [...]
SEOUL, Feb. 13 (Korea Bizwire) — A Children’s Memorial Park, where children who pass away after suffering from cancer and leukemia can rest in peace, will be built in South Korea for the very first time. HiFamily, a South Korean protestant organization, will be opening the Andersen Memorial Park inside ‘W-Story’, a family theme park [...]
Paris, France, Cambridge, Massachusetts (USA) and Houston, Texas (USA), Jan. 7 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers. [...]
SEOUL, Dec. 27 (Korea Bizwire) — The survival rate of South Korean cancer patients topped 70 percent in 2016, sharply up from a decade ago, government data showed Thursday. The rate of people being diagnosed with cancer and living more than five years came to 70.6 percent between 2012 and 2016, up from 54 percent [...]
GWANGJU, Nov. 5 (Korea Bizwire) — Chosun University Hospital in Gwangju announced on Sunday that it is using Watson for Oncology, a medical AI supercomputer designed by IBM Inc., for cancer treatment. Once the information about a patient along with the preliminary diagnosis is entered, Watson delivers the optimum method of treatment by analyzing its [...]
Paris, France, and Cambridge, Massachusetts (USA), Oct. 19 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches in the treatment of cancer, presented NBTXR3 positive Phase II/III Act.in.sarc results in patients with locally advanced Soft Tissue Sarcoma at the European Society for Medical Oncology (ESMO) 2018 Congress [...]
SEOUL, Sept. 27 (Korea Bizwire) — The number of Koreans who succumbed to cancer last year was found to be a record high, but compared to other advanced nations, the mortality rate from cancer remained low. Meanwhile, the mortality rate of South Koreans, in general, was low among other leading nations, but deaths from pneumonia, [...]
PARIS, France and CAMBRIDGE, Massachusetts, Sept. 26 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches in the treatment of cancer, announced today that detailed results of its phase II/III clinical trial of NBTXR3 in patients with soft tissue sarcoma (STS) will be presented by Dr. Sylvie Bonvalot, [...]
NEW YORK, Sept. 25 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday [...]